Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bone Neoplasms × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Melanoma 2 Lymphoma, T-Cell 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of Lung 1

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Radiation 4 Irinotecan 4 Cyclophosphamide 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Methotrexate 2 Ipilimumab 2 Injections 2 Ifosfamide 2 Etoposide 2 Denosumab 2 Cryotherapy 2 Cryosurgery 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06562673 2025-12-29

IACE-OS

Shanghai 6th People's Hospital

Phase 1/2 Completed

Bone Neoplasms, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡